查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1540819

2024-2032 年按测试类型、服务提供者、应用和地区分類的临床实验室服务市场报告

Clinical Laboratory Services Market Report by Test Type, Service Provider, Application, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球临床实验室服务市场规模达到2,447亿美元。对血糖测试、HbA1c 测试和血脂监测等糖尿病管理的诊断测试的需求不断增长，越来越依赖远距医疗来获得临床实验室服务，因为它可以减少医疗保健障碍并增加总体测试量，并且精度趋势不断提高药品对市场有正面影响。

临床实验室服务市场分析：

主要市场驱动因素：对基因测试、基因组定序和分子诊断的需求不断增长，以识别生物标记、遗传变异和精准医疗的特定分子靶标，正在推动市场成长。

主要市场趋势：远距医疗的不断成长趋势使人们即使在偏远地区也能获得医疗保健服务，这提供了良好的市场前景。

地理趋势：北美因其高度发展的医疗保健系统、先进的基础设施和广泛的医疗保健服务而享有领先地位。

竞争格局：临床实验室服务业的一些主要市场参与者包括 Abbott Laboratories、Becton、Dickinson and Company、bioMerieux SA、Charles River Laboratories、F. Hoffmann-La Roche Ltd、Illumina Inc.、NeoGenomics Laboratories Inc.、Quest Diagnostics Incorporated、Siemens Healthcare GmbH (Siemens AG)、Thermo Fisher Scientific Inc. 等。

挑战与机会：虽然市场面临监管合规、高营运成本以及维持测试准确性和可靠性等挑战，但在诊断技术、个人化医疗和远距诊断服务方面也遇到了机会。

临床实验室服务市场趋势：

糖尿病盛行率上升

用于管理糖尿病的诊断测试（例如血糖测试、HbA1c 测试和血脂分析）的需求不断增加。这些测试对于诊断糖尿病、监测血糖水平和评估相关心血管危险因子也至关重要。为了有效控製糖尿病，需要定期监测血糖值。临床实验室非常重要，因为它们可以帮助监测血糖控制、肾功能、血脂水平和其他生物标记。为了预防糖尿病视网膜病变、肾病变和神经病变等併发症，临床实验室会进行筛检测试。这些筛检测试可以及时干预，有助于预防糖尿病的进展。人们更喜欢即时检测 (POCT)，因为它可以快速检测并立即获得结果。此测试对于监测糖尿病患者更为成功。根据IDF糖尿病图谱网站公布的资料，预计到2045年，约有7.83亿人将患有糖尿病。

精准医疗需求不断成长

IMARC Group的报告显示，2023年全球精准医疗市场规模将达到752亿美元。这些测试在临床实验室进行，因为它们有助于预测疾病风险、根据个体的遗传特征选择最有效的疗法并指导治疗决策。为了开发和执行伴随诊断，临床实验室非常重要，这正在加强临床实验室服务市场的成长。伴随诊断是用于识别生物标记以计算任何特定标靶治疗的成功率的测试。了解这一点后，可以优化肿瘤学、传染病和其他治疗领域的治疗选择。分析遗传变异以监测个体对药物的反应非常重要，而药物基因组学在该分析中发挥重要作用。临床实验室提供药物基因组学测试来预测药物疗效、剂量需求和潜在的不良反应。

远距医疗的成长趋势

如今，人们更喜欢远距医疗，因为即使医生身处偏远地区，它也可以帮助与医生联繫。他们还可以透过远距医疗平台获得临床实验室服务，减少医疗保健障碍并增加整体检测量。透过远距医疗远距监控糖尿病等慢性病变得容易。临床实验室对于这种疾病的持续管理和改善患者的治疗结果非常重要。远距医疗市场的主要参与者正在专注于合作和伙伴关係，以扩大其客户群。例如，2023 年，Oracle 和 Zoom Video Communications, Inc. 扩大了合作范围，以提供更快、更轻鬆、更有效的远距医疗服务。临床实验室分发家庭试剂盒，然后处理在家收集的样本，透过远距医疗平台远端提供准确的诊断结果，从而提供良好的临床实验室服务市场前景。

临床实验室服务市场细分：

IMARC Group提供了每个细分市场的主要趋势分析，以及 2024-2032 年全球、区域和国家层面的预测。我们的报告根据测试类型、服务提供者和应用程式对市场进行了分类。

按测试类型划分：

人类和肿瘤遗传学

临床化学

医学微生物学和细胞学

其他的

临床化学占据大部分市场份额

该报告根据测试类型提供了详细的市场细分和分析。这包括人类和肿瘤遗传学、临床化学、医学微生物学和细胞学等。根据该报告，临床化学是最大的细分市场。

临床化学可以定义为评估血液、尿液和其他体液的生化成分的广泛测试。为了诊断和追踪各种医学疾病，这些测试很重要，因为它们可以提供有关荷尔蒙水平、器官功能、电解质平衡和代谢过程的重要资讯。慢性病患者的定期健康检查和后续护理也包括大量的临床化学检测。为了评估一般健康状况并发现问题，经常需要进行完整代谢组 (CMP) 和基本代谢组 (BMP) 等测试。

按服务提供者划分：

医院实验室

独立实验室

临床实验室

医院实验室占据产业最大份额

报告还提供了基于服务提供者的详细市场细分和分析。这包括医院实验室、独立实验室和诊所实验室。报告称，医院实验室占据最大的市场份额。

医院实验室是医疗保健设施的重要组成部分，因为它们与整个患者服务密切相关。在医院环境中，他们为外科手术室、门诊诊所、住院患者和急诊室的患者提供诊断服务。医院实验室通常提供多种诊断测试，以支援不同的患者人口统计和医学专业。临床化学、血液学、免疫学、微生物学、分子诊断和病理学服务都包含在内。他们为各种诊断测试要求提供一站式服务。

按应用划分：

生物分析与实验室化学服务

毒理学测试服务

细胞和基因治疗相关服务

临床前和临床试验相关服务

药物发现及开发相关服务

其他的

生物分析和实验室化学服务代表了领先的细分市场

该报告根据应用程式提供了详细的市场细分和分析。这包括生物分析和实验室化学服务、毒理学测试服务、细胞和基因治疗相关服务、临床前和临床试验相关服务、药物发现和开发相关服务等。根据该报告，生物分析和实验室化学服务占最大的部分。

临床诊断和生物医学研究在很大程度上依赖生物分析和实验室化学服务提供的广泛测试和分析。这些实验室提供的服务包括生物样本中的生物标记、药物浓度、代谢物和其他生化成分的测定。药物动力学 (PK) 和药效学 (PD) 研究是生物分析服务为製药和生物技术产业提供的药物开发过程中的两个重要步骤。临床实验室提供生物分析服务，用于测量生物基质中的药物浓度、评估临床试验中的药物安全性和有效性以及评估药物代谢。

按地区划分：

北美洲

美国

加拿大

亚太

中国

日本

印度

韩国

澳洲

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉丁美洲

巴西

墨西哥

其他的

中东和非洲

北美市场领先，占据最大的临床实验室服务市场份额

该报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，北美是临床实验室服务最大的区域市场。

北美拥有高度发展的医疗保健系统，拥有最先进的基础设施和广泛的医疗保健服务，特别是在美国和加拿大。这包括信誉良好的诊所、医院和诊断实验室网络，提供广泛的临床实验室服务。当谈到全球医疗保健支出时，美国经常名列前茅。临床实验室服务的快速崛起可归因于对医疗保健基础设施、技术和服务的大量投资。疾病监测、定製药物和诊断测试等市场驱动措施得到了医疗保健支出的支持。在美国营运的主要参与者也专注于提供支援新技术的测试。例如，2023 年，荷兰生物技术公司 Detact Diagnostics 宣布计划在其位于美国基恩州立学院的实验室开始进行细菌检测采样。

竞争格局：

市场研究报告也对市场竞争格局进行了全面分析。也提供了所有主要公司的详细资料。临床实验室服务业的一些主要市场参与者包括 Abbott Laboratories、Becton、Dickinson and Company、bioMerieux SA、Charles River Laboratories、F. Hoffmann-La Roche Ltd、Illumina Inc.、NeoGenomics Laboratories Inc.、Quest Diagnostics Incorporated、西门子医疗保健有限公司(Siemens AG) 和Thermo Fisher Scientific Inc.

（请注意，这只是关键参与者的部分列表，报告中提供了完整列表。）

领先的临床实验室服务公司正在积极采取一系列策略来巩固其在市场中的地位并满足不断增长的诊断测试需求。企业正在透过与其他公司合作以及透过收购扩大其服务组合来接触全球更多的患者并提供更广泛的测试选择。例如，2023年，全球创新综合实验室服务领导者Labcorp宣布与马萨诸塞州领先的综合学术医疗系统Tufts Medicine达成协议，第一步收购Tufts Medicine外展实验室业务并选择营运资产迈向更大的策略伙伴关係。大公司也对自动化、数位病理学和下一代定序等尖端技术进行了大量投资，以提高其服务的精度、有效性和周转时间。透过创建和利用基因和分子诊断的特定测试，他们还专注于客製化医学，支持精准医学和针对性治疗。

临床实验室服务市场新闻：

2023 年：DiaCarta Ltd. 宣布，该公司已与新泽西州的Hopkins MedTech Compliance (HMC) 和Hopkins MedTech Lab Services (HML) 建立战略合作伙伴关係，以支持监管合规性和实验室开发测试(LDT) 验证的未满足需求。

2023 年：Aegis Sciences Corporation 收购了 HealthTrackRx 的毒理学业务部门，以增强其毒理学产品组合。

本报告回答的关键问题：

  • 迄今为止，全球临床实验室服务市场表现如何，未来几年将如何表现？
  • 全球市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的市场？
  • 根据测试类型，市场的细分是什么？
  • 市场上最具吸引力的测试类型是什么？
  • 基于服务提供者的市场区隔是什么？
  • 哪个是市场上最具吸引力的服务提供者？
  • 基于应用程式的市场区隔是什么？
  • 市场上最有吸引力的应用是什么？
  • 市场竞争结构如何？
  • 全球临床实验室服务市场的主要参与者/公司有哪些？

本报告回答的关键问题：

  • 迄今为止，全球临床实验室服务市场表现如何，未来几年将如何表现？
  • 全球市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的市场？
  • 根据测试类型，市场的细分是什么？
  • 市场上最具吸引力的测试类型是什么？
  • 基于服务提供者的市场区隔是什么？
  • 哪个是市场上最具吸引力的服务提供者？
  • 基于应用程式的市场区隔是什么？
  • 市场上最有吸引力的应用是什么？
  • 市场竞争结构如何？
  • 全球临床实验室服务市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球临床实验室服务市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按测试类型

  • 人类和肿瘤遗传学
    • 市场趋势
    • 市场预测
  • 临床化学
    • 市场趋势
    • 市场预测
  • 医学微生物学和细胞学
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：按服务供应商

  • 医院实验室
    • 市场趋势
    • 市场预测
  • 独立实验室
    • 市场趋势
    • 市场预测
  • 临床实验室
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：按应用

  • 生物分析与实验室化学服务
    • 市场趋势
    • 市场预测
  • 毒理学测试服务
    • 市场趋势
    • 市场预测
  • 细胞和基因治疗相关服务
    • 市场趋势
    • 市场预测
  • 临床前和临床试验相关服务
    • 市场趋势
    • 市场预测
  • 药物发现及开发相关服务
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • bioMerieux SA
    • Charles River Laboratories
    • F. Hoffmann-La Roche Ltd
    • Illumina Inc.
    • NeoGenomics Laboratories Inc.
    • Quest Diagnostics Incorporated
    • Siemens Healthcare GmbH (Siemens AG)
    • Thermo Fisher Scientific Inc.
Product Code: SR112024A3914

The global clinical laboratory services market size reached US$ 244.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 383.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5% during 2024-2032. The growing demand for diagnostic tests, such as blood glucose tests, HbA1c testing, and lipid profiles to manage diabetes, rising reliance on telehealth to access clinical laboratory services as it can reduce barriers to healthcare and increase overall testing volumes, and increasing trend of precision medicines are positively influencing the market.

Clinical Laboratory Services Market Analysis:

Major Market Drivers: The rising need for genetic testing, genomic sequencing, and molecular diagnostics to identify biomarkers, genetic variations, and specific molecular targets for precision medicines is propelling the market growth.

Key Market Trends: The growing trend of telehealth, which enable people to access healthcare services even at remote locations is offering a favorable market outlook.

Geographical Trends: North America is enjoying the leading position on account of its highly developed healthcare systems with cutting-edge infrastructure and widespread access to healthcare services.

Competitive Landscape: Some of the major market players in the clinical laboratory services industry include Abbott Laboratories, Becton, Dickinson and Company, bioMerieux SA, Charles River Laboratories, F. Hoffmann-La Roche Ltd, Illumina Inc., NeoGenomics Laboratories Inc., Quest Diagnostics Incorporated, Siemens Healthcare GmbH (Siemens AG), Thermo Fisher Scientific Inc., among many others.

Challenges and Opportunities: While the market faces challenges, such as regulatory compliance, high operational costs, and maintaining accuracy and reliability of tests, it also encounters opportunities in diagnostic technologies, personalized medicine, and remote diagnostic services.

Clinical Laboratory Services Market Trends:

Rising prevalence of diabetes

There is a rise in the demand for diagnostic tests, such as blood glucose tests, HbA1c testing, and lipid profiles, to manage diabetes. These tests are also crucial for diagnosing diabetes, monitoring blood sugar levels, and assessing associated cardiovascular risk factors. To effectively manage diabetes, there is a need of monitoring blood glucose levels regularly. Clinical laboratories are very essential as they can help in monitoring glycemic control, kidney function, lipid levels, and other biomarkers. For preventing complications, such as diabetic retinopathy, nephropathy, and neuropathy, clinical laboratories perform screening tests. These screening tests allow for timely intervention that can assist in preventing progression of diabetes. People are preferring point-of-care testing (POCT) as it allows rapid testing and immediate results. This testing is more successful for monitoring patients with diabetes. As per the data published on the website of IDF Diabetes Atlas, it is projected that around 783 million people will be suffering from diabetes by 2045.

Growing demand for precision medicine

The IMARC Group's report shows that the global precision medicine market reached US$ 75.2 Billion in 2023. Genetic testing, genomic sequencing, and molecular diagnostics are important for precision medicines to identify biomarkers, genetic variations, and specific molecular targets. These tests are performed in clinical laboratories, as they help in predicting disease risks, selecting most effective therapies as individual's genetic characteristics, and guiding treatment decisions. To develop and perform companion diagnostics, clinical laboratories are very crucial, which is strengthening the clinical laboratory services market growth. Companion diagnostics are tests used to identify biomarkers to calculate the success rate of any specific targeted therapy. After knowing this, treatment choices in oncology, infectious diseases, and other therapeutic areas can be optimized. It is very important to analyze genetic variations to monitor the respond of medications in individuals, and pharmacogenomic plays an important role in this analysis. Clinical laboratories provide pharmacogenomic testing to predict drug efficacy, dosage requirements, and potential adverse reactions.

Increasing trend of telehealth

People are preferring telehealth nowadays, as it can help connect with doctors even if they are at remote locations. They can also access clinical laboratory services through telehealth platforms, reducing barriers to healthcare and increasing overall testing volumes. It becomes easy to monitor chronic conditions like diabetes remotely through telehealth. Clinical laboratories are very important for the ongoing management of this diseases and improving patient outcomes. Key players operating in the telehealth market are focusing on collaborations and partnerships to expand their customer base. For instance, in 2023, Oracle and Zoom Video Communications, Inc. expanded their collaboration to deliver faster, easier, and more effective telehealth services. Home-based kits are distributed by clinical laboratories and then they process the samples collected at home to provide accurate diagnostic results remotely through telehealth platforms, thereby offering a favorable clinical laboratory services market outlook.

Clinical Laboratory Services Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on test type, service provider, and application.

Breakup by Test Type:

Human and Tumor Genetics

Clinical Chemistry

Medical Microbiology and Cytology

Others

Clinical chemistry accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the test type. This includes human and tumor genetics, clinical chemistry, medical microbiology and cytology, and others. According to the report, clinical chemistry represents the largest segment.

Clinical chemistry can be defined as a broad range of tests that assess the biochemical components of blood, urine, and other bodily fluids. To diagnose and track a variety of medical disorders, these tests are important as they can provide vital information on hormone levels, organ function, electrolyte balance, and metabolic processes. Regular health screenings and follow-up care for patients with chronic diseases also include a large number of clinical chemistry tests. To evaluate general health status and identify problems, tests such as complete metabolic panels (CMP) and basic metabolic panels (BMP) are frequently ordered.

Breakup by Service Provider:

Hospital-Based Laboratories

Stand-Alone Laboratories

Clinic-Based Laboratories

Hospital-based laboratories hold the largest share of the industry

A detailed breakup and analysis of the market based on the service provider have also been provided in the report. This includes hospital-based laboratories, stand-alone laboratories, and clinic-based laboratories. According to the report, hospital-based laboratories account for the largest market share.

Hospital-based laboratories are essential components of healthcare facilities because they are closely linked to the whole range of patient services. Within the hospital setting, they provide diagnostic services for surgical units, outpatient clinics, inpatients, and patients in the emergency room. A wide variety of diagnostic tests are usually available at hospital laboratories to support different patient demographics and medical specialties. Clinical chemistry, hematology, immunology, microbiology, molecular diagnostics, and pathology services are all included in this. They offer a one-stop shop for a variety of diagnostic testing requirements.

Breakup by Application:

Bioanalytical and Lab Chemistry Services

Toxicology Testing Services

Cell and Gene Therapy Related Services

Preclinical and Clinical Trial Related Services

Drug Discovery and Development Related Services

Others

Bioanalytical and lab chemistry services represent the leading market segment

The report has provided a detailed breakup and analysis of the market based on the application. This includes bioanalytical and lab chemistry services, toxicology testing services, cell and gene therapy related services, preclinical and clinical trial related services, drug discovery and development related services, and others. According to the report, bioanalytical and lab chemistry services represent the largest segment.

Clinical diagnostics and biomedical research depend heavily on a wide range of tests and analyses that are provided by bioanalytical and lab chemistry services. Assays for biomarkers, drug concentrations, metabolites, and other biochemical components in biological samples are among the services provided by these labs. Pharmacokinetic (PK) and pharmacodynamic (PD) investigations are two important steps in the drug development process that bioanalytical services provide for the pharmaceutical and biotechnology industries. Clinical laboratories offer bioanalytical services for measuring drug concentrations in biological matrices, evaluating medication safety and efficacy in clinical trials, and assessing drug metabolism.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest clinical laboratory services market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for clinical laboratory services.

North America has highly developed healthcare systems with cutting-edge infrastructure and widespread access to healthcare services, especially in the United States and Canada. This includes a reputable network of clinics, hospitals, and diagnostic labs that provide a wide range of clinical laboratory services. When it comes to healthcare spending worldwide, the US regularly comes in top. The rapid rise of clinical laboratory services can be attributed to the significant investments made in healthcare infrastructure, technology, and services. The market-driving initiatives of illness monitoring, tailored medication, and diagnostic testing are bolstered by healthcare spending. Key players operating in US also focusing on providing tests that support novel technology. For instance, in 2023, Dutch biotech firm Detact Diagnostics' announced about its plans to begin bacterial detection sampling at its laboratory in the Keene State College situated in the US.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the clinical laboratory services industry include Abbott Laboratories, Becton, Dickinson and Company, bioMerieux SA, Charles River Laboratories, F. Hoffmann-La Roche Ltd, Illumina Inc., NeoGenomics Laboratories Inc., Quest Diagnostics Incorporated, Siemens Healthcare GmbH (Siemens AG), and Thermo Fisher Scientific Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Leading clinical laboratory services companies are aggressively pursuing a range of tactics to fortify their positions in the market and satisfy the expanding need for diagnostic tests. Businesses are reaching more patients worldwide and providing a wider choice of tests by partnering with other companies and increasing their service portfolios through acquisitions. For instance, in 2023, Labcorp, a global leader of innovative and comprehensive laboratory services, announced an agreement with Tufts Medicine, a leading integrated academic health system in Massachusetts, to acquire the Tufts Medicine outreach laboratory business and select operating assets as a first step towards a larger strategic partnership. Major firms are also making significant investments in cutting-edge technologies including automation, digital pathology, and next-generation sequencing to increase the precision, effectiveness, and turnaround times of their services. By creating and utilizing specific tests for genetic and molecular diagnostics, they are also concentrating on customized medicine, which supports precision medicine and focused therapeutics.

Clinical Laboratory Services Market News:

In 2023: DiaCarta Ltd. announced that the company has formed strategic partnership with New Jersey-based Hopkins MedTech Compliance (HMC) and Hopkins MedTech Lab Services (HML) to support the unmet needs for regulatory compliance and laboratory developed test (LDT) validation of in vitro diagnostics (IVD) in the United States.

In 2023: Aegis Sciences Corporation acquired HealthTrackRx's Toxicology business unit to enhance its toxicology portfolio.

Key Questions Answered in This Report:

  • How has the global clinical laboratory services market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global market?
  • What is the impact of each driver, restraint, and opportunity on the global market?
  • What are the key regional markets?
  • Which countries represent the most attractive market?
  • What is the breakup of the market based on the test type?
  • Which is the most attractive test type in the market?
  • What is the breakup of the market based on the service provider?
  • Which is the most attractive service provider in the market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global clinical laboratory services market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Clinical Laboratory Services Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 Human and Tumor Genetics
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Clinical Chemistry
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Medical Microbiology and Cytology
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Service Provider

  • 7.1 Hospital-Based Laboratories
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Stand-Alone Laboratories
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Clinic-Based Laboratories
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Bioanalytical and Lab Chemistry Services
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Toxicology Testing Services
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Cell and Gene Therapy Related Services
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Preclinical and Clinical Trial Related Services
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Drug Discovery and Development Related Services
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton, Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 bioMerieux SA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Charles River Laboratories
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 F. Hoffmann-La Roche Ltd
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 Illumina Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 NeoGenomics Laboratories Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Quest Diagnostics Incorporated
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Siemens Healthcare GmbH (Siemens AG)
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Thermo Fisher Scientific Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Clinical Laboratory Services Market: Major Drivers and Challenges
  • Figure 2: Global: Clinical Laboratory Services Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Clinical Laboratory Services Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Clinical Laboratory Services Market: Breakup by Test Type (in %), 2023
  • Figure 5: Global: Clinical Laboratory Services Market: Breakup by Service Provider (in %), 2023
  • Figure 6: Global: Clinical Laboratory Services Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Clinical Laboratory Services Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Clinical Laboratory Services (Human and Tumor Genetics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Clinical Laboratory Services (Human and Tumor Genetics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Clinical Laboratory Services (Clinical Chemistry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Clinical Laboratory Services (Clinical Chemistry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Clinical Laboratory Services (Medical Microbiology and Cytology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Clinical Laboratory Services (Medical Microbiology and Cytology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Clinical Laboratory Services (Other Test Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Clinical Laboratory Services (Other Test Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Clinical Laboratory Services (Hospital-Based Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Clinical Laboratory Services (Hospital-Based Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Clinical Laboratory Services (Stand-Alone Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Clinical Laboratory Services (Stand-Alone Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Clinical Laboratory Services (Clinic-Based Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Clinical Laboratory Services (Clinic-Based Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Clinical Laboratory Services (Bioanalytical and Lab Chemistry Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Clinical Laboratory Services (Bioanalytical and Lab Chemistry Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Clinical Laboratory Services (Toxicology Testing Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Clinical Laboratory Services (Toxicology Testing Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Clinical Laboratory Services (Cell and Gene Therapy Related Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Clinical Laboratory Services (Cell and Gene Therapy Related Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Clinical Laboratory Services (Preclinical and Clinical Trial Related Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Clinical Laboratory Services (Preclinical and Clinical Trial Related Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Clinical Laboratory Services (Drug Discovery and Development Related Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Clinical Laboratory Services (Drug Discovery and Development Related Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Clinical Laboratory Services (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Clinical Laboratory Services (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: North America: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: North America: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: United States: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: United States: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Canada: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Canada: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Asia-Pacific: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Asia-Pacific: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: China: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: China: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Japan: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Japan: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: India: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: India: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: South Korea: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: South Korea: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Australia: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Australia: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Indonesia: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Indonesia: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Others: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Others: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Europe: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Europe: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Germany: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Germany: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: France: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: France: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: United Kingdom: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: United Kingdom: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Italy: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Italy: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Spain: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Spain: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Russia: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Russia: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Latin America: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Latin America: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Brazil: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Brazil: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Mexico: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Mexico: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Others: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Others: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Middle East and Africa: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Middle East and Africa: Clinical Laboratory Services Market: Breakup by Country (in %), 2023
  • Figure 82: Middle East and Africa: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Global: Clinical Laboratory Services Industry: SWOT Analysis
  • Figure 84: Global: Clinical Laboratory Services Industry: Value Chain Analysis
  • Figure 85: Global: Clinical Laboratory Services Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Clinical Laboratory Services Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Clinical Laboratory Services Market Forecast: Breakup by Test Type (in Million US$), 2024-2032
  • Table 3: Global: Clinical Laboratory Services Market Forecast: Breakup by Service Provider (in Million US$), 2024-2032
  • Table 4: Global: Clinical Laboratory Services Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Clinical Laboratory Services Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Clinical Laboratory Services Market: Competitive Structure
  • Table 7: Global: Clinical Laboratory Services Market: Key Players